Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Trans-4-methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid | 191282-48-1 | MFCD03265452 | 99.8% | 254.33 g/mol | C14H22O4 | 5MG
SDP

Catalog No. 5000237708
Encompass_Preferred

trans-C75 ((±)-C75) is the trans enantiomer of C75, a synthetic fatty-acid synthase (FASN) inhibitor used in biochemical and cellular research. It shows reported activity in prostate cancer models (PC3 IC50 ≈ 35 μM at 24 h; LNCaP spheroids IC50 ≈ 50 μM) and is supplied for research use with high reported purity. Molecular formula C14H22O4; molecular weight ≈ 254.33 g/mol.

  • Enantiomer for stereochemistry and mechanism studies.
  • Inhibits fatty acid synthase (FASN) in biochemical assays.
  • Demonstrated cytotoxic activity in cancer cell models.
  • High reported purity (99.8%).
  • Available in small research quantities for in vitro studies.

Catalog No. 50-002-37708 Supplier Medchemexpress LLC Supplier No. HY12364A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

trans-C75 ((±)-C75) is the trans enantiomer of C75, a synthetic fatty-acid synthase (FASN) inhibitor used in biochemical and cellular research. It shows reported activity in prostate cancer models (PC3 IC50 ≈ 35 μM at 24 h; LNCaP spheroids IC50 ≈ 50 μM) and is supplied for research use with high reported purity. Molecular formula C14H22O4; molecular weight ≈ 254.33 g/mol.

  • Enantiomer for stereochemistry and mechanism studies.
  • Inhibits fatty acid synthase (FASN) in biochemical assays.
  • Demonstrated cytotoxic activity in cancer cell models.
  • High reported purity (99.8%).
  • Available in small research quantities for in vitro studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.